Caricamento...

High-affinity peptide-based anticancer vaccination to overcome resistance to immunostimulatory antibodies

We tested how to eradicate long-established immunogenic tumors that were resistant to the monoclonal antibody-mediated blockade of PD-L1 (PD-1 ligand 1) and cytotoxic T lymphocyte-associated protein 4 (CTLA4). Bacterial vaccination with a tumor-specific peptide exhibiting a high affinity for its res...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Binder, David C, Schreiber, Hans
Natura: Artigo
Lingua:Inglês
Pubblicazione: Landes Bioscience 2013
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3923789/
https://ncbi.nlm.nih.gov/pubmed/24563823
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.26704
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !